Evidence map›Paper›PMID 42325654›Full record

ArticleOpen forum infectious diseases2026

Is There Value in Performing Yearly Screening for Latent Tuberculosis Infection by Interferon-Gamma Release Assay Among Patients Living With HIV in Non-Endemic Settings?

Carlo Foppiano Palacios, Amit Achhra, Lydia Barakat, Michael Virata, Ritche Hao, John Baxter, Maricar Malinis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Carlo Foppiano PalaciosDivision of Infectious Diseases, Department of Medicine, Cooper Medical School of Rowan University, Camden, New Jersey, USA.ORCID https://orcid.org/0000-0002-2698-981X
Amit AchhraSection of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0009-0002-8954-345X
Lydia BarakatSection of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.ORCID https://orcid.org/0000-0003-4994-2907
Michael VirataSection of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
Ritche HaoSection of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
John BaxterDivision of Infectious Diseases, Department of Medicine, Cooper Medical School of Rowan University, Camden, New Jersey, USA.ORCID https://orcid.org/0000-0002-0704-9603
Maricar MalinisDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID https://orcid.org/0000-0002-5720-9994

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated the effectiveness of annual LTBI screening via IGRA in people with HIV in non-endemic settings over 5 years. Out of 1898 patients with at least 2 IGRAs, only 12 developed new LTBI, highlighting the low yield of universal screening. Findings support targeted screening per current guidelines.

Indexed as

HIV screeninglatent tuberculosistuberculosis

Identifiers

PMID42325654
PMCPMC13280639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.